Pro-inflammatory cytokine signaling pathways (TNF-α, IL-1β, IFN-γ) (TNF/IL1/IFN pathways)

The TNF-α, IL-1β, and IFN-γ downstream inflammatory pathways represent a complex network of intracellular signaling events triggered by three primary pro-inflammatory cytokines. Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-1 beta (IL-1β) primarily drive the activation of the NF-κB and MAPK pathways through their respective receptors (TNFR and IL-1R), leading to the transcription of genes involved in systemic inflammation and tissue destruction (Brenner et al., 2015, Nature Reviews Immunology). Interferon-gamma (IFN-γ) signals predominantly through the JAK-STAT pathway, specifically activating STAT1 to promote Th1-type immune responses and enhance macrophage activation (Hu and Ivashkiv, 2009, Nature Immunology). These pathways often act synergistically; for instance, TNF-α and IFN-γ can cooperatively induce cell death and amplify the production of other inflammatory mediators (Dinarello, 2011, Blood). Dysregulation of this integrated network is a central driver of chronic autoimmune diseases like rheumatoid arthritis and Crohn's disease, as well as acute conditions like cytokine release syndrome. Therapeutic strategies include biological agents that neutralize the cytokines themselves or small-molecule inhibitors, such as JAK inhibitors, that block the downstream signaling nodes shared by these pathways (O'Shea et al., 2013, Nature Reviews Drug Discovery).

Other names

TNF-alpha / IL-1beta / IFN-gamma downstream inflammatory pathwaysPro-inflammatory cytokine cascadeTh1 inflammatory response axisCytokine-mediated signaling network

Inhibition of ligand-receptor binding (neutralization), blockade of cytokine receptors, or inhibition of downstream signal transducers such as Janus kinases (JAKs) and the NF-κB complex.